TY  - CHAP
M1  - Book, Section
TI  - Chapter 11. Parathyroid Carcinoma
A1  - Chambers, Anthony J.
A1  - Pasieka, Janice L.
A2  - Morita, Shane Y.
A2  - Dackiw, Alan P. B.
A2  - Zeiger, Martha A.
PY  - 2010
T2  - McGraw-Hill Manual: Endocrine Surgery
AB  - Carcinoma  of  the  parathyroid  gland  is  a  rare  endocrine  malignancy,  accounting  for  only  0.005%  of  all  cancer  registrations  in  the  US  National  Cancer  Database  (NCDB).1  Using  information  from  the  Surveillance,  Epidemiology  and  End  Results  (SEER)  database,  the  incidence  in  the  United  States  is  estimated  to  be  5.73  per  10  million  population,  increasing  by  60%  from  1988  to  2003.2  Parathyroid  cancer  accounts  for  0.5%  to  1%  of  cases  of  primary  hyperparathyroidism  (PHPT)  in  series  from  Western  nations  and  2.8  to  5%  of  cases  in  Japan.3–6  It  affects  males  and  females  equally  and  is  evenly  distributed  within  different  socioeconomic  and  racial  groups  in  the  NCBD.1  The  mean  age  of  diagnosis  of  parathyroid  cancer  is  47  to  56  years,  and  73%  of  cases  occur  in  patients  older  than  age  45  years.1,2  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesssurgery.mhmedical.com/content.aspx?aid=6162969
ER  -